BEVACIZUMAB (BV) IN COMBINATION WITH FOLFOXIRI (IRINOTECAN, OXALIPLATIN AND INFUSIONAL 5FU/LV) AS FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER (mCRC): A PHASE II TRIAL BY THE GONO GROUP

Autor: Masi, G., Vasile, E., Loupakis, F., Salvatore, L., Mezi, Silvia, Andreuccetti, Rondini M., Falcone, A.
Jazyk: angličtina
Rok vydání: 2009
Databáze: OpenAIRE